Corebridge Financial Inc. Trims Stake in Ingevity Corporation $NGVT

Corebridge Financial Inc. has slightly lowered its stake in Ingevity Corporation, selling 372 shares during the first quarter. The investment firm now holds 19,016 shares of the NYSE-listed specialty chemicals producer, according to its recent filing with the Securities and Exchange Commission.

Key Takeaways:

  • Corebridge Financial’s Ingevity stake was cut by 1.9%.
  • 372 shares were sold during the first quarter.
  • Corebridge now holds 19,016 shares of Ingevity Corporation.
  • The data comes from a filing with the SEC.
  • Ingevity trades on the NYSE under the ticker NGVT.

Corebridge’s Stake Reduction

Corebridge Financial Inc. has announced a 1.9% reduction in its shares of Ingevity Corporation. The transaction took place during the first quarter, with the institutional investor selling a total of 372 shares. Following this move, Corebridge’s total holdings stand at 19,016 shares.

SEC Filing Confirmation

Details of this stake reduction were published in the company’s most recent disclosure with the Securities and Exchange Commission (SEC). Such filings provide transparency for shareholders and the larger market, offering insight into how institutional investors adjust their portfolios over time.

Ingevity Corporation Profile

Ingevity Corporation, listed on the New York Stock Exchange under the ticker symbol NGVT, specializes in performance chemicals and materials. The details surrounding Corebridge’s reduction in shares highlights the evolving nature of institutional investor activity in the chemicals sector.

Implications for Investors

Although a 1.9% decrease in holdings may not signal a dramatic shift in investor confidence, it underscores the routine adjustments made by institutional investors to re-balance or strategize their portfolios. Market observers often track these filings closely to understand broader investment trends.

Looking Ahead

As Corebridge adapts its positions in various companies, filings like these serve as snapshots of continual movements in the market. While the sale of 372 shares is a relatively small slice of the company’s portfolio, it serves as another example of the intricacies inherent in institutional investment decisions.

More from World

Lakers' Post-Davis Era: Can Doncic Deliver?
by Yardbarker
4 days ago
2 mins read
LA Lakers told they failed to replace Anthony Davis ‘mindset‘ with one player already disappointing
Worker Dies in 60-Foot Fall at NYC Tunnel Site
by Newser
4 days ago
1 min read
Worker Dies in 60-Foot Fall at NYC Tunnel Site
Willows Proclaims National Wildlife Refuge Week
by Appeal Democrat
4 days ago
1 min read
Hawks, Honkers and Hoots at Willows City Council meeting
Vance Condemns Israeli Vote on West Bank
by Daily Express Us
4 days ago
1 min read
JD Vance slams Israel after ‘insulting’ vote in rare public attack
Mike Shildt Reveals He Isn’t Receiving the Money That Was Left on His Contract
Dodgers Notes: Deion Sanders Praises Shohei Ohtani, Pitcher Linked to Trade, LA Heavy Favorites in World Series?
Makhachev vs. Maddalena: UFC 322's Epic Battle
by Yardbarker
4 days ago
1 min read
Conor McGregor Makes His UFC 322 Pick Clear With Savage Advice to Jack Della Maddalena
Topuria Faces Fiery Challenge to Sign Contract
by Capjournal
4 days ago
2 mins read
UFC Star Blasts Ilia Topuria in Fiery Rant: ‘Sign the Contract!’
Tiago Splitter Named Interim Blazers Head Coach
by Realgm
4 days ago
2 mins read
Blazers Elevate Tiago Splitter To Interim Head Coach
China's Economy Shifts Toward Export Reliance
by Newser
4 days ago
1 min read
China Has a Major Domestic Spending Problem
Reclaiming Her Daughter's Legacy: A Mother's Perspective
by Hastingstribune
4 days ago
1 min read
Commentary: My daughter is the face of Operation Midway Blitz. I am reclaiming her legacy
Xbox's Ambitious Profit Goal Sparks Major Changes
by Gamespot
4 days ago
2 mins read
Microsoft’s Sky-High Profit Goals For Xbox May Be Doing More Harm Than Good – Report